Your browser doesn't support javascript.
loading
Bioactive Compounds of Dietary Origin and Their Influence on Colorectal Cancer as Chemoprevention.
Delgado-Gonzalez, Paulina; Garza-Treviño, Elsa N; de la Garza Kalife, David A; Quiroz Reyes, Adriana; Hernández-Tobías, Esther Alhelí.
Afiliación
  • Delgado-Gonzalez P; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey 6440, Mexico.
  • Garza-Treviño EN; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey 6440, Mexico.
  • de la Garza Kalife DA; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey 6440, Mexico.
  • Quiroz Reyes A; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey 6440, Mexico.
  • Hernández-Tobías EA; Facultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León (UANL), Monterrey 6440, Mexico.
Life (Basel) ; 13(10)2023 Sep 28.
Article en En | MEDLINE | ID: mdl-37895359
ABSTRACT
Colorectal cancer (CRC) is one of the most common causes of death and the third most diagnosed cancer worldwide. The tumor microenvironment and cancer stem cells participate in colorectal tumor progression and can dictate malignancy. Nutrition status affects treatment response and the progression or recurrence of the tumor. This review summarizes the main bioactive compounds against the molecular pathways related to colorectal carcinogenesis. Moreover, we focus on the compounds with chemopreventive properties, mainly polyphenols and carotenoids, which are highly studied dietary bioactive compounds present in major types of food, like vegetables, fruits, and seeds. Their proprieties are antioxidant and gut microbiota modulation, important in the intestine because they decrease reactive oxygen species and inflammation, both principal causes of cancer. These compounds can promote apoptosis and inhibit cell growth, proliferation, and migration. Combined with oncologic treatment, a sensitization to first-line colorectal chemotherapy schemes, such as FOLFOX and FOLFIRI, is observed, making them an attractive and natural support in the oncologic treatment of CRC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2023 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2023 Tipo del documento: Article País de afiliación: México